Sponsor Pharmacist

HUSAM

KABLAWI

EDUCATION

BACHELORS OF SCIENCE IN PSYCHOLOGY FLORIDA INTERNATIONAL UNIVERSITY 2010 - 2014 MASTERS OF BUSINESS ADMINISTRATION, CONCENTRATION IN PHARMACEUTICAL MANAGEMENT FAIRLEIGH DICKINSON UNIVERSITY 2017 - 2020

DOCTOR OF PHARMACY FAIRLEIGH DICKINSON UNIVERSITY 2016 - 2020 C L I N I C A L E X P E R I E N C E

LONG TERM CARE GENERATION PHARMACY PRECEPTOR DR. SCHIMPF, BOONTON, NEW JERSEY Assisted in antibiotic stewardship and organized weekly reports Made recommendations for antibiotic adjustments to minimize resistance based on clinical guidelines Worked on COVID-19 anticoagulation recommendations for patients requiring hospitalization HIV/DIABETES CLINIC ZUFALL COMMUNITY HEALTH PRECEPTOR DR. KALHOFF, DOVER, NEW JERSEY Worked on an interdisciplinary team to optimize patients diabetic regimens Assisted in HIV and diabetes patient education and profile review for enhanced chronic management Improved medication adherence using evidence-based pharmaceutical and behavioral approaches P R O F E S S I O N A L H I S T O R Y

REGISTERED PHARMACIST I 2020-CURRENT

CVS HEALTH FLOATER PHARMACIST, DEERFIELD BEACH, FLORIDA Supported the management, oversight and operation of all aspects within the pharmacy Ensured correct medication is dispensed via verification of dose, product and clinical directions Evaluated patient medication profile for drug-drug interactions and communicated with prescribers to problem- solve

Managed workflow in extremely high-volume pharmacies (1000+ prescriptions/day) while maintaining accuracy and safety

Led clinical team and maintained quality assurance through proper handling, storage, reconstitution and administration of thousands of doses of the covid-19 vaccine SENIOR REGULATORY CONSULTANT I 2021-CURRENT

BIOMARIN PHARMACEUTICALS, VIA SYNEOS HEALTH REMOTE, BASED IN MIAMI, FLORIDA Analyzed FDA Guidance Documents and SBAs to find pertinent regulatory information regarding sponsor submission and interactions with FDA to advise regulatory approach Evaluated clinical trial primary endpoints to gauge likelihood of acceptability by FDA, and monitored regulatory events of interest in related studies

Created trackers to monitor regulatory landscape including: breakthrough therapy designations, accelerated approvals, RMAT, and clinical holds

Researched regulatory decision-making history for FDA reviewers to prepare GRT submission strategy

( 3 0 5 ) - 5 0 2 - 9 6 7 3

D R K A B L *****@*****.***

WWW.L I N K E D I N . COM/I N / HUSAMKABLAWI92

C O N T A C T

Accomplishment: contributed research leading to full approval in EU and US for CNP analog Voxzogo, which has orphan drug designation, indicated for linear growth in children with achondroplasia aged 5+ Databases: OrangeBook, Product-Specific Guidance, Cortellis, Biomedtracker, TrialTrove, Dr.Evidence, FactSet, PinkSheet

Reports and Visualizations: SharePoint, Microsoft Office (Excel, Word, PPT), Google Drive

Contact this candidate